UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000028652
Receipt No. R000032793
Official scientific title of the study Kumamoto University Malignancy and Atheroscrelosis study
Date of disclosure of the study information 2017/08/20
Last modified on 2018/02/12 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Kumamoto University Malignancy and Atheroscrelosis study
Title of the study (Brief title) KUMA study
Region
Japan

Condition
Condition Coronary artery disease
Classification by specialty
Cardiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 With progress in medical technology, cardiovascular events in cancer survivors are attracting attention.
Basic objectives2 Others
Basic objectives -Others We sought to examine whether the differential incidence of cardiovascular events after percutaneous coronary intervention with or without malignant diseases.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes target lesion revascularization(TLR) within 1-year
Key secondary outcomes total cardiovascular event (cardiovascular death, nonfatal myocardial infarction, unstable angina pectoris, TLR, non TLR revascularization and hospitalization for heart failure decompensation).
All-cause death

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Those who received percutaneous coronary intervention in our department.
Key exclusion criteria none
Target sample size 1000

Research contact person
Name of lead principal investigator Daisuke Sueta
Organization Kumamoto University
Division name Cardiovacular Medicine
Address 1-1-1 Honjo
TEL 096-373-5175
Email sueta-d@kumamoto-u.ac.jp

Public contact
Name of contact person Daisuke Sueta
Organization Kumamoto University
Division name Cardiovacular Medicine
Address 1-1-1 Honjo
TEL 096-373-5175
Homepage URL
Email sueta-d@kumamoto-u.ac.jp

Sponsor
Institute Cardiovacular Medicine, Kumamoto University
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 08 Month 20 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2007 Year 01 Month 01 Day
Anticipated trial start date
2007 Year 01 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information none

Management information
Registered date
2017 Year 08 Month 13 Day
Last modified on
2018 Year 02 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032793